Novel peptides and peptidomimetics
AssigneesThe University of Auckland, Ocunexus Therapeutics, Inc.
InventorsColin Richard GREEN, Yeri KIM, Bradford James DUFT
Life of this patent
Estimating the term…
Abstract
Compounds and compositions comprising a gap junction channel or hemichannel blocker or inhibitor, and methods of use thereof, are provided for the treatment or prevention of vascular and other diseases, disorders, and conditions.
Claims11
A pharmaceutical composition comprising a compound selected from the group consisting of SEQ ID NOS:1-52 and a pharmaceutically acceptable carrier.
A pharmaceutical composition comprising a compound according to Formula I, and a pharmaceutically acceptable carrier.
A pharmaceutical composition comprising a compound according to Formula II, and a pharmaceutically acceptable carrier.
A pharmaceutical composition comprising a compound according to Formula III, and a pharmaceutically acceptable carrier.
A pharmaceutical composition comprising a compound according to Formula IV, and a pharmaceutically acceptable carrier.
An isolated compound selected from the group consisting of SEQ ID NOS:1-52.
An isolated compound selected according to Formula I.
An isolated compound selected according to Formula II.
An isolated compound selected according to Formula III.
An isolated compound selected according to Formula IV.
Dependencies are inferred from the claim text.